BAYER拜耳品牌怎么样 申请店铺

我要投票 BAYER拜耳在兽药行业中的票数:31 更新时间:2024-11-21
BAYER拜耳是哪个国家的品牌?「BAYER拜耳」是拜耳(中国)有限公司旗下著名品牌。该品牌发源于德国,在1863年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
BAYER拜耳怎么样

创于1863年,德国拜耳集团旗下,世界闻名的非处方药供应商,从事于高分子/医药保健/化工以及农业领域,专注于人类和动物医药生产/研发/销售的全球制药企业


拜耳公司于1863年由弗里德里希-拜耳在德国创建。1899年3月6日拜耳获得了阿司匹林的注册商标,该商标后来成为全世界使用广泛、知名度高的药品品牌之一,并为拜耳带来了难以想象的巨额利润。1925年公司同其他几家化学公司合并建立法本化学工业公司,战后被拆散。1951年成为独立的法本继承公司,称拜耳颜料公司,1972年取名“拜耳公司”。

公司的总部位于德国的勒沃库森,在六大洲的200个地点建有750家生产厂;拥有120,000名员工及350家分支机构,几乎遍布世界各国。高分子、医药保健、化工以及农业是公司的四个支柱产业。公司的产品种类超过10,000种,是德国较大的产业集团。拜耳的发展史就是对更高生活质量的不断追求。

拜耳公司分为3个子集团公司,分别是:拜耳材料科技,拜耳农作物科学,拜耳医药。

拜耳医药的处方药部继续专注于心血管病、糖尿病、感染和泌尿系统等常用药物领域,并加速发展专科药物,如肿瘤药物的开发。

拜耳医药保健是拜耳集团的子公司,总部位于德国勒沃库森。公司在全球范围内经营动物保健、保健消费品、糖尿病保健和处方药等业务。拜耳医药保健的目标是在全球发现并生产可以促进人类和动物健康的产品。2005年拜耳医药保健全球销售额达94亿欧元。

拜耳历史

染料推销员Friedrich Bayer和主染色员Johann Friedrich Weskott合作创立了“Friedr. Bayer et comp.”,以生产和销售合成染料。
尽管使用煤焦油衍生物生产染料的历史仅有几年,却为年轻的化工行业开创了新的业务领域。

公司在Wuppertal-Elberfeld设立了科学实验室(1878至1912年间为公司总部),制定了行业研究的新标准。经过不懈努力及孜孜探索,拜耳研发出了众多中间产品、染料和药品,其中包括“世纪之药”——阿司匹林。阿司匹林由Felix Hoffmann开发,于1899年投放市场。在这段时期,拜耳已在国际上占有一席之地,出口远至中国,并在俄罗斯、法国、比利时、英国和美国设立了分公司。阿司匹林也在拜耳的努力下,成为了畅销的药品之一。

随着时间的推移,事实证明Elberfeld已无法满足继续扩张的需求。因此,拜耳首先于1891年收购了Dr. Carl Leverkus & Sons North of Cologne工厂,继而购买了莱茵河沿岸的一些其它土地。1912年,公司总部迁至勒沃库森。

二战以后,拜耳又一次集中精力投身研发工作,为重新建立业务运营奠定了基础。聚氨酯化工的进一步发展、新作物保护产品、聚丙烯腈纤维Dralon等纤维、热塑材料模克隆、新合成纤维染料和其他诸多发明均在公司的扩张进程中发挥了举足轻重的作用。心脑血管药、皮肤抗真菌药、广谱抗生素等新产品相继从拜耳的制药实验室诞生。

1988年,拜耳庆祝成立125周年。同年,拜耳集团成为在东京股票交易所上市的德国公司。

1994年,拜耳收购了Sterling Winthrop的北美自我药疗企业,因为此次收购使公司得以在美国重新使用“拜耳”作为公司名称。这是75年来拜耳以自己的名称并以拜耳十字标识作为企业标识在美国开展运营。1995年,美国的Miles Inc.被重新命名为拜耳公司。

2002年,拜耳股票以BAY为股票代号在纽约证券交易所上市。同年7月1日,拜耳集团开始大规模的一次重组,从而形成了公司目前的组织结构。


Founded in 1863, Bayer Group, a world-famous over-the-counter drug supplier, is engaged in polymer / healthcare / chemical and agricultural fields. Bayer company, a global pharmaceutical enterprise focusing on human and animal medicine production / R & D / sales, was founded in Germany by Friedrich Bayer in 1863. On March 6, 1899, Bayer obtained the registered trademark of aspirin, which later became one of the widely used and well-known drug brands in the world, and brought unimaginable huge profits to Bayer. In 1925, the company merged with several other chemical companies to establish French chemical industry company, which was split up after the war. In 1951, it became an independent successor company to the French law, called Bayer paint company, and in 1972, it was named "Bayer company". Headquartered in Leverkusen, Germany, the company has 750 factories in 200 locations on six continents, 120000 employees and 350 branches, almost all over the world. Polymer, medicine and health care, chemical industry and agriculture are the four pillar industries of the company. The company has more than 10000 kinds of products and is a large industrial group in Germany. Bayer's development history is the constant pursuit of higher quality of life. Bayer company is divided into three sub groups: Bayer materials technology, Bayer crop science and Bayer medicine. Bayer's prescription medicine department continues to focus on the common drug fields such as cardiovascular disease, diabetes, infection and urinary system, and accelerate the development of specialized drugs, such as cancer drugs. Bayer healthcare is a subsidiary of Bayer Group, headquartered in Leverkusen, Germany. The company is engaged in animal health care, health consumer goods, diabetes health care and prescription medicine business all over the world. The goal of Bayer healthcare is to discover and produce products around the world that can promote human and animal health. In 2005, the global sales of Bayer healthcare reached 9.4 billion euros. Friedrich Bayer, a salesman of Bayer's historical dyes, and Johann Friedrich weskott, the chief dyeing officer, jointly founded "friedr. Bayeretcomp." to produce and sell synthetic dyes. Although the use of coal tar derivatives to produce dyes has only a few years of history, it has created a new business field for the young chemical industry. The company has set up a scientific laboratory in Wuppertal Elberfeld (the headquarters of the company from 1878 to 1912), which has formulated new standards for industry research. Through unremitting efforts and exploration, Bayer has developed many intermediate products, dyes and drugs, including aspirin, the "medicine of the century". Aspirin was developed by Felix Hoffmann and launched in 1899. During this period, Bayer had a place in the world, exported to China as far as possible, and set up branches in Russia, France, Belgium, the United Kingdom and the United States. Aspirin has also become one of the best-selling drugs thanks to Bayer's efforts. Over time, Elberfeld has proved unable to meet the needs of continued expansion. As a result, Bayer first acquired the Dr. Carl leverkus & Sons northofcologne plant in 1891, and then acquired some other land along the Rhine. In 1912, the company's headquarters moved to Leverkusen. After World War II, Bayer once again focused on R & D, laying the foundation for the re establishment of business operations. The further development of polyurethane chemical industry, new crop protection products, polyacrylonitrile fiber dralon and other fibers, thermoplastic material mold clone, new synthetic fiber dye and many other inventions all play an important role in the expansion process of the company. New products such as cardiovascular and cerebrovascular drugs, skin antifungal drugs and broad-spectrum antibiotics were successively born from Bayer's pharmaceutical laboratory. In 1988, Bayer celebrated its 125th anniversary. In the same year, Bayer Group became a German company listed on the Tokyo Stock Exchange. In 1994, Bayer acquired Sterling Winthrop's North American self medication company, because the acquisition allowed the company to reuse "Bayer" as its name in the United States. This is Bayer's 75 years of operation in the United States with its own name and Bayer cross logo as the corporate logo. In 1995, miles Inc. of the United States was renamed Bayer company. In 2002, Bayer stock was listed on the New York Stock Exchange under the symbol of bay. On July 1 of the same year, Bayer Group began a large-scale restructuring, thus forming the current organizational structure of the company.

本文链接: https://brand.waitui.com/06a926478.html 联系电话:400-8100360,021-63618282

千城特选小程序码

7×24h 快讯

李彦宏:百度文库AI功能月活用户超5000万,同比增长超300%

36氪获悉,百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏披露,今年9月,百度文库AI功能月活用户突破5000万,同比增长超300%。此外,用户的付费意愿不断增强,第三季度文库的订阅收入同比增长23%。在近期举办的百度世界2024上,百度文库与百度网盘联合推出了工具类智能体“自由画布”,亮相首日即吸引超20万人排队预约。

2小时前

李彦宏:Q3智能云营收快速增长,AI收入占比提升至超11%

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏公布,三季度,百度智能云营收达49亿元,同比增长11 %,Non-GAAP 经营利润率同比提升。其中,AI相关收入占比持续提升至超11%。据IDC报告,在中国AI公有云市场,百度智能云已连续五年位居第一。

2小时前

热门中概股美股盘前普跌,拼多多跌超10%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超10%,小鹏汽车、爱奇艺跌超4%,百度、B站跌超2%,蔚来跌超1%。

2小时前

我国载人登月任务已全面进入初样研制阶段

中国载人航天工程总设计师周建平21日在深圳召开的第六届载人航天学术大会上表示,我国载人月球探测工程载人登月任务已经完成了前期的关键技术攻关和深化论证,目前全面进入了初样研制阶段。“目前,长征十号运载火箭、梦舟载人飞船、揽月月面着陆器、载人月球车等初样产品正在紧张研制过程中。不少初样产品已经研制出来,正在进行相关测试。”周建平说。(新华社)

2小时前

李彦宏:百度将于2025年初发布新版大模型

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏透露,百度将于2025年初发布文心大模型的新版本,以巩固在基础模型上的领先优势。李彦宏表示,11月,文心大模型日均调用量达15亿,日均处理Tokens文本超1.7万亿。相较一年前首次披露的5000万次日均调用量,增长30倍。

2小时前

本页详细列出关于海利Hile的品牌信息,含品牌所属公司介绍,海利Hile所处行业的品牌地位及优势。
咨询